At Edwards-Hunt Group (EHG), we bring together the voice of the patient and the rigor of clinical research to deliver high-impact, real-world data solutions. With deep expertise in clinical operations and biospecimen acquisition, we partner with life sciences companies, diagnostics firms, clinical research networks—and increasingly, hedge funds and private equity firms—to deliver research that drives both outcomes and investment insight.
Our founder, Alicia Sable-Hunt, RN, brings over 25 years of clinical research and nursing leadership to every engagement. Her approach blends firsthand understanding of the patient journey with a sharp focus on protocol execution, regulatory navigation, and strategic site activation.
We specialize in:
Our track record spans rare diseases, oncology, sexual health, infectious diseases, and market-entry support for diagnostics and therapeutics.
We believe clinical research should reflect the realities of the people it’s designed to serve. By integrating patient insights into our operational model and offering deep market intelligence, we generate data that is meaningful, reproducible, and strategically aligned with sponsor and investor goals.
Whether you're preparing a study, launching a product, or evaluating an investment, our team can help you navigate the clinical research landscape with precision and purpose. Contact us to learn more.
This website uses cookies. By continuing to use this site, you accept our use of cookies.